Foshan Second People's Hospital Trials

Foshan Second People's Hospital	Welcome, Profile Billing Logout

59 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Zhang, Bo

NCT06263348: A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Recruiting

2000

RoW

Dorzagliatin tablets

Hua Medicine Limited, Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd.

Type2diabetes

04/26

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases

04/25

NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

NCT06472908: Efficacy and Safety of Colchicine After PCI

Recruiting

8862

RoW

Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo

Wuhan Union Hospital, China

Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine

03/28

08/28

RIDER, NCT05794971: Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases

Recruiting

126

RoW

Regorafenib and DIBIRI, Drug: Irinotecan, Procedure: TACE, Device: drug eluting-bead, Regorafenib

Sun Yat-sen University

Colorectal Cancer Liver Metastases, Regorafenib

03/27

03/28

Peri-E, NCT06688656: Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC

Not yet recruiting

RoW

Pemetrexed 500 mg/m2, carboplatin, Sintilimab

Shanghai Chest Hospital

Lung Cancer

03/26

03/28

NCT03866525: OH2 Oncolytic Viral Therapy in Solid Tumors

Recruiting

1/2

300

RoW

OH2 injection, with or without irinotecan or HX008

Binhui Biopharmaceutical Co., Ltd.

Solid Tumor, Gastrointestinal Cancer

08/25

NCT04762602: A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations

Active, not recruiting

Europe, US

HMPL-306

Hutchmed

Isocitrate Dehydrogenase Gene Mutation

03/25

09/25

NCT04764474: A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH

Terminated

Europe, US

HMPL-306

Hutchmed

Isocitrate Dehydrogenase Gene Mutation

01/25

NCT04936178: A Study of NB003 in Patients with Advanced Malignancies

Recruiting

258

Europe, US, RoW

NB003 tablets

Ningbo Newbay Technology Development Co., Ltd

Advanced Solid Tumor

07/25

12/25

DILI-P, NCT02961413: A Prospective Cohort Study on Drug-induced Liver Injury in China（）

Recruiting

N/A

10000

RoW

Drug Induced Liver Disease Study Group

Drug-induced Liver Injury

12/30

NCT04121520: Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey

Completed

N/A

200

Europe, Japan, RoW

Questionnaire

Hepatopancreatobiliary Surgery Institute of Gansu Province, LanZhou University, Shandong Provincial Hospital, Xingtai People's Hospital, Zhejiang University, Ankara University, Chiba University Graduate School of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, S. Orsola-Malpighi Hospital, University of Bologna, Universidade Federal de Pernambuco, Hanyang University College of Medicine

Portal Hypertension, Cirrhosis, Liver

08/21

08/22

COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction

Recruiting

N/A

250

RoW

Dexmedetomidine (DEX), Placebo (Saline)

Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd.

ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection

12/24

12/25

NCT05375123: Reference Range for Tissue Motion Tracking of Mitral Annulus Displacement in Chinese Han Singleton Pregnancies

Recruiting

N/A

660

RoW

Ultrasound image acquisition

First Hospital of China Medical University

Pregnancy

06/23

06/24

NCT05547841: Normal Reference Value for Echocardiography in Chinese Han Pregnancies

Recruiting

N/A

680

RoW

Echocardiography acquisition

First Hospital of China Medical University

Pregnancy

08/23

08/24

NCT06282796: Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Recruiting

N/A

600

RoW

Echocardiography

First Hospital of China Medical University

Breast Cancer

12/26

12/28

NCT06229197: Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer

Not yet recruiting

N/A

176

Billroth II reconstruction, Braun Anastomosis

Sichuan University

Gastric Cancer, Surgery, Anastomosis, Gastrostomy

12/26

12/27

NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

Recruiting

N/A

1860

RoW

Drug-coated balloon, Guideline-directed medical treatment

Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd

Acute Coronary Syndrome (ACS)

12/27

12/30

NCT06455644: Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion

Recruiting

N/A

238

RoW

CT group, DSA group

First Affiliated Hospital of Shantou University Medical College

Atrial Fibrillation, Arrhythmias, Cardiac, Heart Diseases, Cardiovascular Diseases

10/26

07/31

NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus

Recruiting

N/A

184

RoW

Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter

Shanghai Bluesail Boyuan Medical Technology Co., Ltd.

Coronary Artery Disease, Intravascular Lithotripsy

12/24

09/25

NCT06794801: Evaluating the Safety and Efficacy of Drug-Coated Autoperfusion Balloons Versus Conventional Drug-Coated Balloons Guided by IVUS-OCT Multimodal Imaging for Treating Acute Myocardial Infarction: OPERA-AMI Study

Not yet recruiting

N/A

134

RoW

Drug Coated Autoperfusion Balloon Dilatation Catheter（DCAB）, Conventional Drug coated balloon (DCB), Bingo® PTCA Drug Delivery System

LanZhou University

ST Segment Elevation Myocardial Infarction (STEMI)

12/26

12/30

NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma

Recruiting

N/A

300

RoW

Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Hepatocellular Carcinoma

03/26

BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Recruiting

N/A

336

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

01/27

05/27

Zhang, Min

HS-10234-401, NCT06743438: Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB

Active, not recruiting

640

RoW

Tenofovir Amibufenamide（TMF）, HS-10234

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Hepatitis B, Chronic

06/24

09/29

NCT04565262: Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

Not yet recruiting

200

RoW

NAs+IFN-α

Beijing 302 Hospital

HBeAg Positive Chronic Hepatitis B

07/23

09/23

ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Recruiting

364

RoW

Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult, Pseudomonas Aeruginosa Infection

10/25

12/25

NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed

1412

RoW

Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA

Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital

Acute Ischemic Stroke

06/23

NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

Recruiting

1630

RoW

Alteplase, rt-PA, Tenecteplase, TNK-tPA

Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd

Acute Ischemic Stroke

11/23

03/24

STEP, NCT06465485: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

Active, not recruiting

476

RoW

Benralizumab, Fasenra

AstraZeneca

Severe Eosinophilic Asthma

10/25

03/26

NCT06323213: Efficacy and Safety Study of 610 in Patients With Severe Asthma

Not yet recruiting

480

610, Placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Asthma

06/26

09/26

NCT05975268: A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

Active, not recruiting

747

RoW

JS005 (recombinant humanized monoclonal antibody against IL-17A)

Shanghai Junshi Bioscience Co., Ltd.

Moderate to Severe Chronic Plaque Psoriasis

08/25

10/25

TQC2731-III-01, NCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Recruiting

660

RoW

TQC2731 injection, Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Asthma

06/27

TRAILBLAZER-ALZ 5, NCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

Recruiting

1500

Europe, RoW

Donanemab, (LY3002813), Placebo

Eli Lilly and Company

Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

04/27

NCT05528679: A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma

Not yet recruiting

120

RoW

610 100mg, 610 300mg, placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Asthma

09/23

NCT06438757: Trial of JYB1904 in Patients With Allergic Asthma

Recruiting

RoW

JYB1904, Omalizumab

Jemincare

Allergic Asthma

10/25

NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

Completed

129

RoW

ICP-488 Tablets, ICP-488 Placebo

Beijing InnoCare Pharma Tech Co., Ltd.

Moderate to Severe Plaque Psoriasis

08/24

09/24

NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

Completed

305

RoW

SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan

Shanghai Pharmaceuticals Holding Co., Ltd

Diabetic Kidney Disease

12/24

NCT06680947: A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma

Not yet recruiting

225

610, Placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Asthma

09/26

04/27

TQC2731-Ⅱ-04, NCT06707883: A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Recruiting

258

RoW

TQC2731 injection, TQC2731 Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Chronic Obstructive Pulmonary Disease

12/26

09/27

NCT04562870 / 2020-003809-60: A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants with Previously Treated Myelofibrosis

	Jul 2023 - Dec 2023 : Top-line data from XPORT-MF-035 trial for myeloﬁbrosis
	First patient dosed as a monotherapy in patients with 2L myelofibrosis
	Dec 2021 - Dec 2021: First patient dosed as a monotherapy in patients with 2L myelofibrosis

Active, not recruiting

112

Europe, US, RoW

Selinexor, Physician's Choice Treatment

Karyopharm Therapeutics Inc

Myelofibrosis

01/25

NCT06122831: A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

Recruiting

1/2

RoW

TQ05105 Tablets, TQB3617 Capsules

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Myelofibrosis

12/26

04/27

NCT05584306: A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma

Active, not recruiting

RoW

610 30mg group, 610 100mg group, 610 300mg group, Placebo 30mg group, Placebo 100mg group, Placebo 300mg group

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Asthma

09/23

NCT06199700: Esketamine for the Treatment of Rett Syndrome

Active, not recruiting

RoW

Esketamine hydrochloride

Children's Hospital of Fudan University

Rett Syndrome

04/24

05/25

CARTinNS, NCT04561557: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Recruiting

RoW

CT103A cells, Cyclophosphamide and fludarabine

Tongji Hospital, Nanjing IASO Biotechnology Co., Ltd.

Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Idiopathic Inflammatory Myopathies, Multiple Sclerosis, Autoimmune Encephalitis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), POEMS Syndrome

02/27

05/27

NCT06387082: A Clinical Study of HMPL-506 in Patients With Hematological Malignancies

Recruiting

132

RoW

HMPL-506, Two strengths of HMPL-506 tablets (25 mg and 100 mg) will be used for this clinical study

Hutchmed

Hematological Malignancies

10/27

12/27

SAFE-APD, NCT03598387: Automated Peritoneal Dialysis Versus Intermittent Hemodialysis in Acute Kidney Injury

Recruiting

N/A

100

RoW

Automated peritoneal dialysis, Intermittent hemodialysis

Limeng Chen, First Hospital of China Medical University, First Affiliated Hospital Xi'an Jiaotong University, Beijing Anzhen Hospital, Xiangya Hospital of Central South University, Baxter Healthcare Corporation

Acute Kidney Injury

12/22

NCT06393257: Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis

Recruiting

N/A

RoW

Oscillation and Lung Expansion, Postural drainage, Anti-infective therapy, Mucolytic

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult

09/25

05/26

NCT05293405: Neuroinflammatory PET Imaging in Autoimmune Encephalomyelitis

Recruiting

N/A

100

RoW

18F-DPA-714 PET

Ruijin Hospital

Autoimmune Encephalomyelitis

12/23

12/24

NCT05845151: Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis

Recruiting

N/A

RoW

68Ga-FAPI-04 PET

Ruijin Hospital

Lupus Nephritis

12/23

04/24

NCT06760273: Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)

Recruiting

N/A

364

RoW

No Intervention: Observational Cohort

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult

12/27

JY231 NID, NCT06797024: JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

Recruiting

N/A

RoW

JY231 Injection

Tongji Hospital

Autoimmune Diseases of the Nervous System

12/26

03/27

NCT05371873: A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer

Active, not recruiting

N/A

250

RoW

Liver resection method

First Affiliated Hospital of Zhejiang University

Hepatocellular Carcinoma

03/25

SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Not yet recruiting

N/A

1000

RoW

benralizumab

AstraZeneca

Chronic Obstructive Pulmonary Disease

01/26

NCT03190538: Nonalcoholic Steatohepatitis in Chinese Children

Recruiting

N/A

400

RoW

No intervention

Humanity and Health Research Centre, Beijing 302 Hospital

Non-Alcoholic Fatty Liver Disease

05/27

05/28

COAST, NCT03653156: China Cognition and Aging Study

Recruiting

N/A

100000

RoW

Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Afﬁliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital

Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia

01/38

CFAN, NCT03657732: The Chinese Familial Alzheimer's Network

Recruiting

N/A

40000

RoW

Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Afﬁliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital

Alzheimer Disease, Familial Alzheimer Disease (FAD)

01/38

NCT04694430: A Multi-center Study to Determine the Prevalence and Influence of Pertussis on COPD Exacerbation in Shenzhen

Not yet recruiting

N/A

500

RoW

Blood sample, Data collection, Throat swab

Shenzhen People's Hospital

COPD Exacerbation, Pertussis

06/21

12/21

Chen, Sinian

NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Zhang, Bo

NCT06263348: A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Recruiting

2000

RoW

Dorzagliatin tablets

Hua Medicine Limited, Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd.

Type2diabetes

04/26

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

04/25

NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

NCT06472908: Efficacy and Safety of Colchicine After PCI

Recruiting

8862

RoW

Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo

Wuhan Union Hospital, China

Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine

03/28

08/28

RIDER, NCT05794971: Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases

Recruiting

126

RoW

Regorafenib and DIBIRI, Drug: Irinotecan, Procedure: TACE, Device: drug eluting-bead, Regorafenib

Sun Yat-sen University

Colorectal Cancer Liver Metastases, Regorafenib

03/27

03/28

Peri-E, NCT06688656: Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC

Not yet recruiting

RoW

Pemetrexed 500 mg/m2, carboplatin, Sintilimab

Shanghai Chest Hospital

Lung Cancer

03/26

03/28

NCT03866525: OH2 Oncolytic Viral Therapy in Solid Tumors

Recruiting

1/2

300

RoW

OH2 injection, with or without irinotecan or HX008

Binhui Biopharmaceutical Co., Ltd.

Solid Tumor, Gastrointestinal Cancer

08/25

NCT04762602: A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations

Active, not recruiting

Europe, US

HMPL-306

Hutchmed

Isocitrate Dehydrogenase Gene Mutation

03/25

09/25

NCT04764474: A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH

Terminated

Europe, US

HMPL-306

Hutchmed

Isocitrate Dehydrogenase Gene Mutation

01/25

NCT04936178: A Study of NB003 in Patients with Advanced Malignancies

Recruiting

258

Europe, US, RoW

NB003 tablets

Ningbo Newbay Technology Development Co., Ltd

Advanced Solid Tumor

07/25

12/25

DILI-P, NCT02961413: A Prospective Cohort Study on Drug-induced Liver Injury in China（）

Recruiting

N/A

10000

RoW

Drug Induced Liver Disease Study Group

Drug-induced Liver Injury

12/30

NCT04121520: Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey

Completed

N/A

200

Europe, Japan, RoW

Questionnaire

Portal Hypertension, Cirrhosis, Liver

08/21

08/22

COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction

Recruiting

N/A

250

RoW

Dexmedetomidine (DEX), Placebo (Saline)

Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd.

ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection

12/24

12/25

NCT05375123: Reference Range for Tissue Motion Tracking of Mitral Annulus Displacement in Chinese Han Singleton Pregnancies

Recruiting

N/A

660

RoW

Ultrasound image acquisition

First Hospital of China Medical University

Pregnancy

06/23

06/24

NCT05547841: Normal Reference Value for Echocardiography in Chinese Han Pregnancies

Recruiting

N/A

680

RoW

Echocardiography acquisition

First Hospital of China Medical University

Pregnancy

08/23

08/24

NCT06282796: Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Recruiting

N/A

600

RoW

Echocardiography

First Hospital of China Medical University

Breast Cancer

12/26

12/28

NCT06229197: Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer

Not yet recruiting

N/A

176

Billroth II reconstruction, Braun Anastomosis

Sichuan University

Gastric Cancer, Surgery, Anastomosis, Gastrostomy

12/26

12/27

NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

Recruiting

N/A

1860

RoW

Drug-coated balloon, Guideline-directed medical treatment

Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd

Acute Coronary Syndrome (ACS)

12/27

12/30

NCT06455644: Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion

Recruiting

N/A

238

RoW

CT group, DSA group

First Affiliated Hospital of Shantou University Medical College

Atrial Fibrillation, Arrhythmias, Cardiac, Heart Diseases, Cardiovascular Diseases

10/26

07/31

NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus

Recruiting

N/A

184

RoW

Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter

Shanghai Bluesail Boyuan Medical Technology Co., Ltd.

Coronary Artery Disease, Intravascular Lithotripsy

12/24

09/25

Not yet recruiting

N/A

134

RoW

Drug Coated Autoperfusion Balloon Dilatation Catheter（DCAB）, Conventional Drug coated balloon (DCB), Bingo® PTCA Drug Delivery System

LanZhou University

ST Segment Elevation Myocardial Infarction (STEMI)

12/26

12/30

NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma

Recruiting

N/A

300

RoW

Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Hepatocellular Carcinoma

03/26

BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Recruiting

N/A

336

RoW

Endovascular treatment, Intravenous thrombolysis (Alteplase)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment

01/27

05/27

Zhang, Min

HS-10234-401, NCT06743438: Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB

Active, not recruiting

640

RoW

Tenofovir Amibufenamide（TMF）, HS-10234

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Hepatitis B, Chronic

06/24

09/29

NCT04565262: Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

Not yet recruiting

200

RoW

NAs+IFN-α

Beijing 302 Hospital

HBeAg Positive Chronic Hepatitis B

07/23

09/23

ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Recruiting

364

RoW

Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult, Pseudomonas Aeruginosa Infection

10/25

12/25

NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed

1412

RoW

Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA

Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital

Acute Ischemic Stroke

06/23

NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

Recruiting

1630

RoW

Alteplase, rt-PA, Tenecteplase, TNK-tPA

Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd

Acute Ischemic Stroke

11/23

03/24

STEP, NCT06465485: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

Active, not recruiting

476

RoW

Benralizumab, Fasenra

AstraZeneca

Severe Eosinophilic Asthma

10/25

03/26

NCT06323213: Efficacy and Safety Study of 610 in Patients With Severe Asthma

Not yet recruiting

480

610, Placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Asthma

06/26

09/26

NCT05975268: A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

Active, not recruiting

747

RoW

JS005 (recombinant humanized monoclonal antibody against IL-17A)

Shanghai Junshi Bioscience Co., Ltd.

Moderate to Severe Chronic Plaque Psoriasis

08/25

10/25

TQC2731-III-01, NCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Recruiting

660

RoW

TQC2731 injection, Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Asthma

06/27

TRAILBLAZER-ALZ 5, NCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

Recruiting

1500

Europe, RoW

Donanemab, (LY3002813), Placebo

Eli Lilly and Company

Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

04/27

NCT05528679: A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma

Not yet recruiting

120

RoW

610 100mg, 610 300mg, placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Asthma

09/23

NCT06438757: Trial of JYB1904 in Patients With Allergic Asthma

Recruiting

RoW

JYB1904, Omalizumab

Jemincare

Allergic Asthma

10/25

NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

Completed

129

RoW

ICP-488 Tablets, ICP-488 Placebo

Beijing InnoCare Pharma Tech Co., Ltd.

Moderate to Severe Plaque Psoriasis

08/24

09/24

NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

Completed

305

RoW

SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan

Shanghai Pharmaceuticals Holding Co., Ltd

Diabetic Kidney Disease

12/24

NCT06680947: A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma

Not yet recruiting

225

610, Placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Asthma

09/26

04/27

TQC2731-Ⅱ-04, NCT06707883: A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Recruiting

258

RoW

TQC2731 injection, TQC2731 Placebo

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Chronic Obstructive Pulmonary Disease

12/26

09/27

NCT04562870 / 2020-003809-60: A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants with Previously Treated Myelofibrosis

	Jul 2023 - Dec 2023 : Top-line data from XPORT-MF-035 trial for myeloﬁbrosis
	First patient dosed as a monotherapy in patients with 2L myelofibrosis
	Dec 2021 - Dec 2021: First patient dosed as a monotherapy in patients with 2L myelofibrosis

Active, not recruiting

112

Europe, US, RoW

Selinexor, Physician's Choice Treatment

Karyopharm Therapeutics Inc

Myelofibrosis

01/25

NCT06122831: A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

Recruiting

1/2

RoW

TQ05105 Tablets, TQB3617 Capsules

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Myelofibrosis

12/26

04/27

NCT05584306: A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma

Active, not recruiting

RoW

610 30mg group, 610 100mg group, 610 300mg group, Placebo 30mg group, Placebo 100mg group, Placebo 300mg group

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Asthma

09/23

NCT06199700: Esketamine for the Treatment of Rett Syndrome

Active, not recruiting

RoW

Esketamine hydrochloride

Children's Hospital of Fudan University

Rett Syndrome

04/24

05/25

CARTinNS, NCT04561557: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Recruiting

RoW

CT103A cells, Cyclophosphamide and fludarabine

Tongji Hospital, Nanjing IASO Biotechnology Co., Ltd.

02/27

05/27

NCT06387082: A Clinical Study of HMPL-506 in Patients With Hematological Malignancies

Recruiting

132

RoW

HMPL-506, Two strengths of HMPL-506 tablets (25 mg and 100 mg) will be used for this clinical study

Hutchmed

Hematological Malignancies

10/27

12/27

SAFE-APD, NCT03598387: Automated Peritoneal Dialysis Versus Intermittent Hemodialysis in Acute Kidney Injury

Recruiting

N/A

100

RoW

Automated peritoneal dialysis, Intermittent hemodialysis

Acute Kidney Injury

12/22

NCT06393257: Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis

Recruiting

N/A

RoW

Oscillation and Lung Expansion, Postural drainage, Anti-infective therapy, Mucolytic

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult

09/25

05/26

NCT05293405: Neuroinflammatory PET Imaging in Autoimmune Encephalomyelitis

Recruiting

N/A

100

RoW

18F-DPA-714 PET

Ruijin Hospital

Autoimmune Encephalomyelitis

12/23

12/24

NCT05845151: Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis

Recruiting

N/A

RoW

68Ga-FAPI-04 PET

Ruijin Hospital

Lupus Nephritis

12/23

04/24

NCT06760273: Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)

Recruiting

N/A

364

RoW

No Intervention: Observational Cohort

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult

12/27

JY231 NID, NCT06797024: JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

Recruiting

N/A

RoW

JY231 Injection

Tongji Hospital

Autoimmune Diseases of the Nervous System

12/26

03/27

NCT05371873: A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer

Active, not recruiting

N/A

250

RoW

Liver resection method

First Affiliated Hospital of Zhejiang University

Hepatocellular Carcinoma

03/25

SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Not yet recruiting

N/A

1000

RoW

benralizumab

AstraZeneca

Chronic Obstructive Pulmonary Disease

01/26

NCT03190538: Nonalcoholic Steatohepatitis in Chinese Children

Recruiting

N/A

400

RoW

No intervention

Humanity and Health Research Centre, Beijing 302 Hospital

Non-Alcoholic Fatty Liver Disease

05/27

05/28

COAST, NCT03653156: China Cognition and Aging Study

Recruiting

N/A

100000

RoW

Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia

01/38

CFAN, NCT03657732: The Chinese Familial Alzheimer's Network

Recruiting

N/A

40000

RoW

Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Afﬁliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital

Alzheimer Disease, Familial Alzheimer Disease (FAD)

01/38

NCT04694430: A Multi-center Study to Determine the Prevalence and Influence of Pertussis on COPD Exacerbation in Shenzhen

Not yet recruiting

N/A

500

RoW

Blood sample, Data collection, Throat swab

Shenzhen People's Hospital

COPD Exacerbation, Pertussis

06/21

12/21

Chen, Sinian

NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting

9000

RoW

Aspirin 100 mg Oral Tablet, Matching Placebo

Guangdong Provincial People's Hospital, The George Institute

CKD (Chronic Kidney Disease) Stage 5D

09/26

12/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites